Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1616 results

First-in-human experience with EasyCross: a novel catheter for a safe and correct aortic valve crossing

14 Jun 2024

This EIJ image highlights a new device designed to enhance the safety and efficiency of ViV TAVI procedures, particularly TAV-in-TAV, by reducing attempts to cross the valve and preventing guidewire misnavigation, thereby minimizing complications and procedure time.

First-in-human experience with EasyCross: a novel catheter for a safe and correct aortic valve crossing

TAVI for today and tomorrow - What matters the most to patients?

28 May 2024

Watch the replay of this webinar with R. Hahn, K. Hayashida, M. Joner and S. Redwood on how to illustrate how TAVI would optimise the full spectrum of lifetime management to all patients and much more!

TAVI for today and tomorrow- What matters the most to patients?

TAVR in challenging anatomies

17 May 2024 – From EuroPCR 2024

This session focuses on navigating TAVR procedures in complex anatomical scenarios. It covers topics such as optimizing the position of a TAVR valve in a stentless bioprosthesis, managing an unexpected deep position of a TAVR implant, dealing with a completely radiolucent failing surgical bioprosthetic valve, and...

TAVR in challenging anatomies

TAVI: how to prevent stroke

17 May 2024 – From EuroPCR 2024

This session focuses on strategies for preventing stroke during TAVI procedures. It features case presentations and discussions on the use of cerebral protection devices, including a novel full-body embolic protection device, and the management of complications such as cerebral hyperperfusion syndrome.

TAVI: how to prevent stroke

Transcatheter solutions for combined valve disease

17 May 2024 – From EuroPCR 2024

This session delves into the transcatheter management of patients with combined valve disease, including cases of concomitant aortic stenosis and mitral regurgitation, failed bioprostheses in both the aortic and mitral valves, and severe aortic regurgitation after previous valve-sparing root replacement. The session features case presentations and...

Transcatheter solutions for combined valve disease

Scientific highlights, clinical trial updates and key learnings from EuroPCR 2024

17 May 2024 – From EuroPCR 2024

Davide Capodanno presents notable trial updates, coronary devices, and key takeaways from EuroPCR 2024. Highlights include the SOLVE-TAVI and IDEAL-LM trials at 5 years, BIOADAPTOR at 2 years, advancements in drug-coated balloons and DES, as well as insights from REC-CAGEFREE II, LANDMARK, and NOTION-2.

References

  • SOLVE-TAVI: Feistritzer HJ, et al....
EuroPCR 2024 Scientific highlights, clinical trial updates and key learnings

New evidence on TAVI from PCR Companions

17 May 2024 – From EuroPCR 2024

This session features selected EuroPCR 2024 abstract submissions presenting the latest evidence on TAVI. Topics include device success in valve-in-valve TAVI, next-day discharge after TAVI, comparative network meta-analysis of PCI strategies in TAVI patients, factors associated with thrombosis treatment response, and outcomes of a novel balloon-expandable...

New evidence on TAVI from PCR Companions

TAVI: procedural complications - Part 1

17 May 2024 – From EuroPCR 2024

This session, comprising selected EuroPCR 2024 Clinical Case submissions, focuses on the management of various procedural complications that can arise during Transcatheter Aortic Valve Implantation (TAVI). Participants will delve into cases involving unexpected outcomes, such as nosecone-related issues, dysphagia and haematemesis, and frozen leaflets in self-expanding...

Navigating TAVI Complications: Strategies for Success

Pivotal study on the ShortCut transcatheter aortic valve leaflet splitting device

16 May 2024

Coronary obstruction is a major concern in patients undergoing TAVI for degenerated bioprostheses (valve-in-valve [ViV]) and is associated with a 30-day mortality rate of around 50%.1 While several transcatheter techniques to lacerate bioprosthetic valve leaflets prior to TAVI placement (such as BASILICA) have been described, they are...

Pivotal study on the ShortCut transcatheter aortic valve leaflet splitting device

Contemporary TAVI cases: perspectives from three different continents

16 May 2024 – From EuroPCR 2024

This session provides perspectives from three different continents on the management of complex TAVI cases. It features case presentations and discussions on topics such as TAVR for the correction of aortic pseudoaneurysm, TAV-in-TAV intervention, and the management of aortic stenosis in patients with hypertrophic obstructive cardiomyopathy....

Contemporary TAVI cases: perspectives from three different continents

Expanding the heart team - Improved TAVI outcomes through pre-and post-procedure collaboration

16 May 2024 – From EuroPCR 2024

In this session, learn how to advance heart team collaboration through optimized TAVI pre-work-up and refined severe aortic stenosis patient selection, ensuring accurate intervention indications. Gain hands-on insights for effective post-TAVI strategies, explore procedural and valve refinements that simplify post-TAVI PCI, and stay informed on the...

Expanding the heart team - Improved TAVI outcomes through pre-and post-procedure collaboration

Align for the future with case-based discussions on next generation balloon expandable transcatheter heart valve technology

16 May 2024 – From EuroPCR 2024

Join this EuroPCR 2024 session to delve into the cutting-edge innovations and techniques shaping transcatheter heart valve interventions. Witness firsthand the versatility of the Myval Octacor THV platform, navigating through challenging scenarios with ease, explore the significance of lifetime patient management in TAVI, unveiling the novel...

Align for the future with case-based discussions on next generation balloon expandable transcatheter heart valve technology

TAVI: when calcifications are the major issues

16 May 2024 – From EuroPCR 2024

This session explores various challenging TAVI cases where severe aortic valve calcification was the main obstacle. Presenters share their experiences and strategies in overcoming these complex anatomical issues, including the use of techniques like the buddy balloon technique, snare technique, and innovative approaches to cross the...

TAVI: when calcifications are the major issues

TAVI indications: real dilemmas

16 May 2024 – From EuroPCR 2024

This session comprises selected clinical case submissions that explore real-world dilemmas and challenges faced by interventional cardiologists in TAVI procedures. Participants will delve into discussions on topics such as left bundle branch area pacing after TAVR, challenges in TAVI, simultaneous CardioFlow Optimisation, coronary access post-TAVI, complex...

TAVI indications: real dilemmas

Coronary issues before, during and after TAVI

16 May 2024 – From EuroPCR 2024

This session presents a series of challenging clinical cases highlighting the complex interplay between coronary artery disease and transcatheter aortic valve implantation (TAVI). Attendees will witness real-world scenarios, including high-risk PCI with concomitant severe aortic stenosis, the management of degenerated aortic bioprostheses with the risk of...

Coronary issues before, during and after TAVI

The landscape of structural heart interventions

16 May 2024 – From EuroPCR 2024

This session provides a comprehensive overview of the management of structural heart disease, focusing on the differences in procedural approaches for aortic and mitral interventions. Attendees will learn effective strategies to manage procedural complications, as well as how to adapt patient pathways for various structural heart...

The landscape of structural heart interventions

TAVI: how to deal with aortic regurgitation

16 May 2024 – From EuroPCR 2024

This session will explore various cases of TAVI for the management of aortic regurgitation, including patients with pure aortic regurgitation, large annuli, low coronary height, and left ventricular assist devices. Discussions will focus on the transcatheter approach, device selection, and techniques to address these challenging scenarios.

TAVI: how to deal with aortic regurgitation

TAVI: managing acute procedural complications

16 May 2024 – From EuroPCR 2024

From deep implantation challenges to embolization and iatrogenic dissections, each presentation highlights techniques for addressing critical procedural hurdles. Topics include bailout strategies, managing embolized valves, complex second valve placements, and handling unusual TAVR scenarios, offering insights on navigating complications and ensuring procedural safety.

TAVI: managing acute procedural complications

TAVI: procedural complications - Part 2

16 May 2024 – From EuroPCR 2024

This session focuses on the management of procedural complications during transcatheter aortic valve implantation (TAVI). It presents a series of challenging cases, including valve-in-valve TAVI with complications, acute cardiogenic shock during valve-in-valve TAVI, and various other complications such as left ventricular perforation, fistula formation, and lost...

TAVI: procedural complications -  Part 2

Abstracts from the Call for submissions - Nurses and Allied Professionals

16 May 2024 – From EuroPCR 2024

This session features selected abstracts from the call for submissions, focusing on the contributions of nurses and allied health professionals in the field of interventional cardiology. The presentations cover topics such as patient experience in the TAVI process, insights into the use of intravascular imaging and...

Abstracts from the Call for submissions - Nurses and Allied Professionals